Page last updated: 2024-08-24

mk 0591 and thromboxane b2

mk 0591 has been researched along with thromboxane b2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Lepeleire, I; De Schepper, PJ; Depré, M; Larson, P; Lin, C; Porras, A; Schwartz, J; Van Hecken, A; Verbesselt, R1
Akiyama, K; Ishii, T; Mita, H1

Trials

1 trial(s) available for mk 0591 and thromboxane b2

ArticleYear
Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.
    International journal of clinical pharmacology research, 1998, Volume: 18, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Digestive System; Double-Blind Method; Drug Interactions; Drug Tolerance; Humans; Ibuprofen; Indoles; Kidney; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Quinolines; Thromboxane B2

1998

Other Studies

1 other study(ies) available for mk 0591 and thromboxane b2

ArticleYear
Generation of thromboxane A2 from highly purified human sinus mast cells after immunological stimulation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1999, Volume: 60, Issue:3

    Topics: 5-Lipoxygenase-Activating Proteins; Alternative Splicing; Antibodies, Anti-Idiotypic; Carrier Proteins; Cell Separation; Dose-Response Relationship, Drug; Histamine Release; Humans; Indoles; Mast Cells; Membrane Proteins; Methacrylates; Nasal Mucosa; Paranasal Sinuses; Prostaglandin D2; Quinolines; RNA, Messenger; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase

1999